Providence Capital Advisors’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
Other funds holding USNA
Providence Capital Advisors's USNA Position: Q2 2026 in Review
Providence Capital Advisors opened a new position in Usana Health Sciences (USNA) in Q2 2026: 109 shares worth $2.33K. The stake represents ﹤0.01% of the portfolio and ranks #346 among its holdings. This is a return to the name: Providence Capital Advisors previously reported a position in USNA as recently as Q3 2024.
Providence Capital Advisors first reported a position in USNA in Q4 2017 and has held it in 29 quarters since. The position peaked at $29K in Q3 2018. 137 funds tracked by Wall St. Rank hold USNA as of Q2 2026.
- Providence Capital Advisors held 109 shares of Usana Health Sciences worth $2.33K as of Q2 2026.
- Usana Health Sciences was a new Providence Capital Advisors position in Q2 2026.
- Usana Health Sciences made up ﹤0.01% of Providence Capital Advisors's portfolio in Q2 2026, its #346 holding.
- Providence Capital Advisors first reported a position in Usana Health Sciences in Q4 2017 and has held it in 29 quarters since.
- Providence Capital Advisors's Usana Health Sciences position peaked at $29K in Q3 2018.
- 137 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.
Based on Providence Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.